Carcinogenesis, Vol. 20, No. 7, 1201-1208,
July 1999
© 1999 Oxford University Press
Cancer Biology |
Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF
Department of Molecular and Integrative Physiology, Kansas Cancer Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA
An elevation in total MAP kinase activity and expression has been observed in breast cancer tissue. However, the mechanisms underlying these changes in kinase activity and regulation by growth factors are not well characterized. In these studies, the effect of the potent mammary mitogen, epidermal growth factor (EGF), on the activation of the mitogen-activated protein kinases, ERK1 and ERK2 (extracellular regulated protein kinases 1 and 2, respectively), was compared in primary cultures of normal mouse mammary epithelial cells and in a hormone-responsive mouse mammary tumor. In normal epithelium, EGF stimulated an early rise in ERK activity at 4 min followed by a rapid decline, whereas a sustained (1 h) elevation of ERK activity was observed in the tumor cells. The time course of ERK activity in both cell types coincided with the phosphorylation state of the EGF receptor, suggesting that altered regulation of EGF receptor phosphorylation or EGF receptor turnover produces an enhanced ERK response to EGF in tumor cells. The MEK inhibitor, PD 098059 inhibited EGF-stimulated proliferation and ERK activity in a parallel, dose-dependent manner showing that ERK activation is at least permissive for the proliferative response to EGF. In addition, tumor cells showed a 4-fold elevation in basal (or ligand-independent) activity over normal cells without an increase in total enzyme level, and a preferential activation of ERK1 by EGF. These EGF-dependent and -independent changes in ERK regulation in the hormone-responsive mammary tumor underscore how multiple alterations in the regulation of this pathway may play a role in mammary tumorigenesis.
Abbreviations: EGF, epidermal growth factor; ERK, extracellular regulated protein kinase; MAP kinase, mitogen-activated protein kinase.
1 To whom correspondence should be addressed Email: wimagawa{at}kumc.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Zhang, S. Kalyankrishna, M. Wislez, N. Thilaganathan, B. Saigal, W. Wei, L. Ma, I. I. Wistuba, F. M. Johnson, and J. M. Kurie Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines Am. J. Pathol., January 1, 2007; 170(1): 366 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sotgia, T. M. Williams, W. Schubert, F. Medina, C. Minetti, R. G. Pestell, and M. P. Lisanti Caveolin-1 Deficiency (-/-) Conveys Premalignant Alterations in Mammary Epithelia, with Abnormal Lumen Formation, Growth Factor Independence, and Cell Invasiveness Am. J. Pathol., January 1, 2006; 168(1): 292 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Shida, J. Kitayama, K. Mori, T. Watanabe, and H. Nagawa Transactivation of Epidermal Growth Factor Receptor Is Involved in Leptin-Induced Activation of Janus-Activated Kinase 2 and Extracellular Signal-Regulated Kinase 1/2 in Human Gastric Cancer Cells Cancer Res., October 15, 2005; 65(20): 9159 - 9163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Greco, M G Elia, A Muscella, S Romano, C Storelli, and S Marsigliante Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture J. Endocrinol., August 1, 2005; 186(2): 291 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Shah and P. W. Sylvester {gamma}-Tocotrienol Inhibits Neoplastic Mammary Epithelial Cell Proliferation by Decreasing Akt and Nuclear Factor {kappa}B Activity Experimental Biology and Medicine, April 1, 2005; 230(4): 235 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tsuiki, M. Tnani, I. Okamoto, L. C. Kenyon, D. R. Emlet, M. Holgado-Madruga, I. S. Lanham, C. J. Joynes, K. T. Vo, and A. J. Wong Constitutively Active Forms of c-Jun NH2-terminal Kinase Are Expressed in Primary Glial Tumors Cancer Res., January 1, 2003; 63(1): 250 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-C. Choi, C.-J. Tai, C.-R. Tzeng, N. Auersperg, and P. C.K. Leung Adenosine Triphosphate Activates Mitogen-Activated Protein Kinase in Pre-Neoplastic and Neoplastic Ovarian Surface Epithelial Cells Biol Reprod, January 1, 2003; 68(1): 309 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-C. Choi, S. K. Kang, C.-J. Tai, N. Auersperg, and P. C. K. Leung Follicle-Stimulating Hormone Activates Mitogen-Activated Protein Kinase in Preneoplastic and Neoplastic Ovarian Surface Epithelial Cells J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2245 - 2253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, E. Duysen, A. L. Yaktine, A. Au, W. Wang, and D. F. Birt Dietary energy restriction inhibits ERK but not JNK or p38 activity in the epidermis of SENCAR mice Carcinogenesis, April 1, 2001; 22(4): 607 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Ellerbroek, J. M. Halbleib, M. Benavidez, J. K. Warmka, E. V. Wattenberg, M. S. Stack, and L. G. Hudson Phosphatidylinositol 3-Kinase Activity in Epidermal Growth Factor-stimulated Matrix Metalloproteinase-9 Production and Cell Surface Association Cancer Res., March 1, 2001; 61(5): 1855 - 1861. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Clarke, F. Leonessa, J. N. Welch, and T. C. Skaar Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance Pharmacol. Rev., March 1, 2001; 53(1): 25 - 72. [Abstract] [Full Text] [PDF]
|
|